Health
First human trial of AstraZeneca COVID-19 vaccine shows promise – Canada.com
LONDON — AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, with the stron…
LONDON — AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, with the strongest response seen in people who received two doses.
The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medica…
-
General20 hours agoVote counting begins for Townsville mayoral by-election
-
General22 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
General23 hours agoPolice to patrol Melbourne shopping centres in 90-day youth crime prevention trial
-
General17 hours agoEngland completes sole Ashes warm-up match with flurry of runs to Ollie Pope, Joe Root